Novartis Ag (NVSEF) Other Non-Current Assets (2009 - 2026)

Novartis Ag has disclosed Other Non-Current Assets across 14 years of filings, most recently posting $200.0 million for Q1 2026.

• Other Non-Current Assets for Q1 2026 came in at $200.0 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $200.0 million (changed N/A YoY), and the FY2025 annual result was $509.0 million, down 85.48% from the prior year.
• Other Non-Current Assets came in at $200.0 million for Q1 2026 at Novartis Ag, down from $509.0 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $4.5 billion in Q2 2025 to a low of $200.0 million in Q1 2026.
• The 5-year median for Other Non-Current Assets is $1.2 billion (2023), against an average of $2.0 billion.
• Across the five-year window, Other Non-Current Assets soared 303.64% in 2022 and slumped 85.48% in 2025, its largest moves.
• Novartis Ag's Other Non-Current Assets stood at $1.1 billion in 2022, then rose by 8.02% to $1.2 billion in 2023, then surged by 192.33% to $3.5 billion in 2024, then plunged by 85.48% to $509.0 million in 2025, then tumbled by 60.71% to $200.0 million in 2026.
• The last three Other Non-Current Assets figures came in at $200.0 million (Q1 2026), $509.0 million (Q4 2025), and $4.5 billion (Q2 2025), per Business Quant data.